100 related articles for article (PubMed ID: 23437535)
1. [Reactogenicity associated to the intradermally administered inactivated poliovirus vaccine with a needle-free injector].
Tejeda Fuentes A; de Armas López J; Silva Sosa M; Alemañy Bueno N; Carmenate García A; García González G; Díaz González M; Resik Aguirre S
Rev Cubana Med Trop; 2011; 63(1):38-43. PubMed ID: 23437535
[TBL] [Abstract][Full Text] [Related]
2. Fractional doses of inactivated poliovirus vaccine in Oman.
Mohammed AJ; AlAwaidy S; Bawikar S; Kurup PJ; Elamir E; Shaban MM; Sharif SM; van der Avoort HG; Pallansch MA; Malankar P; Burton A; Sreevatsava M; Sutter RW
N Engl J Med; 2010 Jun; 362(25):2351-9. PubMed ID: 20573923
[TBL] [Abstract][Full Text] [Related]
3. Randomized controlled clinical trial of fractional doses of inactivated poliovirus vaccine administered intradermally by needle-free device in Cuba.
Resik S; Tejeda A; Lago PM; Diaz M; Carmenates A; Sarmiento L; Alemañi N; Galindo B; Burton A; Friede M; Landaverde M; Sutter RW
J Infect Dis; 2010 May; 201(9):1344-52. PubMed ID: 20350164
[TBL] [Abstract][Full Text] [Related]
4. Intradermal fractional booster dose of inactivated poliomyelitis vaccine with a jet injector in healthy adults.
Soonawala D; Verdijk P; Wijmenga-Monsuur AJ; Boog CJ; Koedam P; Visser LG; Rots NY
Vaccine; 2013 Aug; 31(36):3688-94. PubMed ID: 23770332
[TBL] [Abstract][Full Text] [Related]
5. Needle-free jet injector intradermal delivery of fractional dose inactivated poliovirus vaccine: Association between injection quality and immunogenicity.
Resik S; Tejeda A; Mach O; Sein C; Molodecky N; Jarrahian C; Saganic L; Zehrung D; Fonseca M; Diaz M; Alemany N; Garcia G; Hung LH; Martinez Y; Sutter RW
Vaccine; 2015 Oct; 33(43):5873-5877. PubMed ID: 26192350
[TBL] [Abstract][Full Text] [Related]
6. Equivalent schedules of intradermal fractional dose versus intramuscular full dose of inactivated polio vaccine for prevention of poliomyelitis.
Jaiswal N; Singh S; Agarwal A; Chauhan A; Thumburu KK; Kaur H; Singh M
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011780. PubMed ID: 31858595
[TBL] [Abstract][Full Text] [Related]
7. Immune responses after fractional doses of inactivated poliovirus vaccine using newly developed intradermal jet injectors: a randomized controlled trial in Cuba.
Resik S; Tejeda A; Mach O; Fonseca M; Diaz M; Alemany N; Garcia G; Hung LH; Martinez Y; Sutter R
Vaccine; 2015 Jan; 33(2):307-13. PubMed ID: 25448109
[TBL] [Abstract][Full Text] [Related]
8. Priming after a fractional dose of inactivated poliovirus vaccine.
Resik S; Tejeda A; Sutter RW; Diaz M; Sarmiento L; Alemañi N; Garcia G; Fonseca M; Hung LH; Kahn AL; Burton A; Landaverde JM; Aylward RB
N Engl J Med; 2013 Jan; 368(5):416-24. PubMed ID: 23363495
[TBL] [Abstract][Full Text] [Related]
9. Randomized controlled study of fractional doses of inactivated poliovirus vaccine administered intradermally with a needle in the Philippines.
Cadorna-Carlos J; Vidor E; Bonnet MC
Int J Infect Dis; 2012 Feb; 16(2):e110-6. PubMed ID: 22153001
[TBL] [Abstract][Full Text] [Related]
10. Safety and immunogenicity of inactivated poliovirus vaccine based on Sabin strains with and without aluminum hydroxide: a phase I trial in healthy adults.
Verdijk P; Rots NY; van Oijen MG; Oberste MS; Boog CJ; Okayasu H; Sutter RW; Bakker WA
Vaccine; 2013 Nov; 31(47):5531-6. PubMed ID: 24063976
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the Immunogenicity of Various Booster Doses of Inactivated Polio Vaccine Delivered Intradermally Versus Intramuscularly to HIV-Infected Adults.
Troy SB; Kouiavskaia D; Siik J; Kochba E; Beydoun H; Mirochnitchenko O; Levin Y; Khardori N; Chumakov K; Maldonado Y
J Infect Dis; 2015 Jun; 211(12):1969-76. PubMed ID: 25567841
[TBL] [Abstract][Full Text] [Related]
12. Intradermal administration of fractional doses of the inactivated poliovirus vaccine in a campaign: a pragmatic, open-label, non-inferiority trial in The Gambia.
Bashorun AO; Badjie Hydara M; Adigweme I; Umesi A; Danso B; Johnson N; Sambou NA; Fofana S; Kanu FJ; Jeyaseelan V; Verma H; Weldon WC; Oberste MS; Sutter RW; Jeffries D; Wathuo M; Mach O; Clarke E
Lancet Glob Health; 2022 Feb; 10(2):e257-e268. PubMed ID: 34951974
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous administration of meningococcal C conjugate vaccine and diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in children: a randomized double-blind study.
Halperin SA; McDonald J; Samson L; Danzig L; Santos G; Izu A; Smith B; MacDonald N
Clin Invest Med; 2002 Dec; 25(6):243-51. PubMed ID: 12516995
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTPa-HBV-IPV/Hib combination vaccine in healthy infants.
Knuf M; Habermehl P; Cimino C; Petersen G; Schmitt HJ
Vaccine; 2006 May; 24(22):4727-36. PubMed ID: 16616973
[TBL] [Abstract][Full Text] [Related]
15. An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine.
Langley JM; Predy G; Guasparini R; Law B; Diaz-Mitoma F; Whitstitt P; Tapiero B; Dionne M; Tomovici A; Mills E; Halperin SA
Vaccine; 2007 Jan; 25(6):1121-5. PubMed ID: 17045366
[TBL] [Abstract][Full Text] [Related]
16. Needle adapters for intradermal administration of fractional dose of inactivated poliovirus vaccine: Evaluation of immunogenicity and programmatic feasibility in Pakistan.
Saleem AF; Mach O; Yousafzai MT; Khan A; Weldon WC; Oberste MS; Sutter RW; Zaidi AKM
Vaccine; 2017 May; 35(24):3209-3214. PubMed ID: 28479178
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and effectiveness of routine immunization with 1 or 2 doses of inactivated poliovirus vaccine: systematic review and meta-analysis.
Grassly NC
J Infect Dis; 2014 Nov; 210 Suppl 1(Suppl 1):S439-46. PubMed ID: 24634499
[TBL] [Abstract][Full Text] [Related]
18. Immune response of infants to fractional doses of intradermally administered inactivated poliovirus vaccine.
Nirmal S; Cherian T; Samuel BU; Rajasingh J; Raghupathy P; John TJ
Vaccine; 1998; 16(9-10):928-31. PubMed ID: 9682339
[TBL] [Abstract][Full Text] [Related]
19. Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age.
Black S; Friedland LR; Ensor K; Weston WM; Howe B; Klein NP
Pediatr Infect Dis J; 2008 Apr; 27(4):341-6. PubMed ID: 18316985
[TBL] [Abstract][Full Text] [Related]
20. Boosting Immune Responses Following Fractional-Dose Inactivated Poliovirus Vaccine: A Randomized, Controlled Trial.
Resik S; Tejeda A; Diaz M; Okayasu H; Sein C; Molodecky NA; Fonseca M; Alemany N; Garcia G; Hung LH; Martinez Y; Sutter RW
J Infect Dis; 2017 Jan; 215(2):175-182. PubMed ID: 28073858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]